top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights
Search

Bristol Myers Squibb buys Mirati for up to $5.8B

  • Oct 12, 2023
  • 1 min read

Lawrenceville, NJ, October 9, 2023 (Yahoo Finance) -- Bristol-Myers Squibb (BMY) has announced its acquisition of cancer drug manufacturer Mirati Therapeutics (MRTX) for a potential sum of $5.8 billion. This strategic move will expand Bristol-Myers Squibb's cancer drug portfolio.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments

Life Science Headlines
bottom of page